[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"patient-outcomes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:patient-outcomes":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,43,76],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100609668","program-in-oncology-for-tribal-health-systems-100609668",false,"NCT07217574","Program in Oncology for Tribal Health Systems.","Care Coordination and Communication Program in Oncology for Tribal Health Systems (C3PO)","Inclusion Criteria:\n\n* Participants must be at least 18 years of age, within eight weeks of newly diagnosed cancer confirmed by pathology\u002Fimaging, navigated through the NANP at SCC and have verbal fluency in English.\n\nExclusion Criteria:\n\n* Participants in the Phase 1 open pilot will not be eligible for the Phase 2 RCT.","ALL","18 Years",{"count":19,"type":20},187,"ESTIMATED","INTERVENTIONAL",[23],"NA","This clinical trial aims to develop and implement more navigation assistance programs tailored specifically for Native American cancer patients, addressing the current lack of available support. The goal is to improve communication barriers within the healthcare system by fostering a collaborative approach between the Stephenson Cancer Center (SCC) and tribally operated healthcare systems (ITU). Through this partnership, the trial seeks to enhance patient outcomes by providing culturally sensitive, coordinated care.",[26],"Patient Outcomes",[28,29],"American Indian (AI)","American Native (AN)","RECRUITING","2026-06-08",{"date":33,"type":34},"2026-06-11","ACTUAL",{"date":36,"type":34},"2026-02-11",{"date":38,"type":20},"2031-03",{"name":40,"class":41},"University of Oklahoma","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":21,"phases":52,"briefSummary":53,"conditions":54,"keywords":64,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":42},"100564856","the-effect-of-patient-education-and-in-the-operating-room-family-interview-practices-on-patient-outcomes-using-virtual-reality-in-cholecystectomy-patients-100564856","NCT06634615","The Effect of Patient Education and in the Operating Room Family Interview Practices on Patient Outcomes Using Virtual Reality in Cholecystectomy Patients","The Effect of Patient Education and in the Operating Room Family Interview Practices on Patient Outcomes Using Virtual Reality in Cholecystectomy Patients: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients who volunteered to participate in the study,\n* who were 18 years of age or older,\n* who would undergo elective laparoscopic cholecystectomy surgery,\n* who had no vision, hearing and communication problems,\n* whose relatives had a smartphone and internet connection,\n* whose stress intensity was higher than 3 points (between 1-10 points) met the inclusion criteria.\n\nExclusion Criteria:\n\n* Patients with complaints of dizziness,\n* psychiatric disorders,\n* persistent sleep problems were excluded from the study.\n* Patients who voluntarily left the study,\n* interrupted the family video call with VR,\n* felt discomfort during VR application,\n* developed any allergy to the goggle material,\n* filled out the data collection forms incompletely and\u002For incorrectly will be excluded from the study.",{"count":51,"type":20},60,[23],"This study was planned to be a randomized controlled experimental study to determine the effect of patient education and family interview practices using virtual reality on stress intensity, anxiety and information need levels, sleep quality and satisfaction with the preparation process for surgery in cholecystectomy patients. The main questions it aims to answer are:\n\n* Is there a significant difference in stress intensity, anxiety, and information need levels between patients who received and did not receive patient education with VR glasses in the ward before cholecystectomy surgery?\n* Is there a significant difference in stress intensity and anxiety levels between patients who received and did not receive video family interviews with VR glasses in the operative waiting area before cholecystectomy surgery?\n* Is there a significant difference in stress intensity, anxiety, and sleep quality levels at discharge of groups that received different VR interventions?\n* What is the postoperative sleep quality of patients with low preoperative anxiety levels?\n* What is the satisfaction of patients who received VR with the surgery preparation process? The patients participating in the study will be numbered according to the order of hospitalization and assigned to one of the control, education, education+interview groups in accordance with the randomization list. Face-to-face communication will be established with each patient in the ward on the day of hospitalization, in the preoperative waiting area when they come to the operating room and in the ward on the day of discharge. Depending on the groups in which the patients are included, they will be shown an educational video using virtual reality goggles and\u002For will be allowed to meet with their families. No application will be made to the control group and the ward routine will continue.",[55,56,57,58,59,60,61,62,63,26],"Cholecystectomy, Laparoscopic","Virtual Reality","Patient Education","Family Interviews","Operating Room","Anxiety","Stress","Sleep Quality","Patient Satisfaction",[65,56,57,66,26,60,61,62,63],"Cholecystectomy","Operating Room Family Interview","2025-05-08",{"date":69,"type":34},"2025-05-09",{"date":71,"type":34},"2025-01-05",{"date":73,"type":20},"2025-08",{"name":75,"class":41},"Marmara University",{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":83,"sex":16,"minAge":84,"maxAge":85,"enrollmentInfo":86,"targetDuration":4,"studyType":21,"phases":88,"briefSummary":90,"conditions":91,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":100,"leadSponsor":102,"locationsCount":42},"100404713","phase-4-the-prime-study-a-randomized-controlled-prospective-study-100404713","NCT04549935","The PRIME Study: A Randomized, Controlled, Prospective Study","A Randomized, Controlled, PRospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the treatMEnt of Post-operative Inflammation in Patients Who Plan to Undergo Refractive Lens Exchange (RLE)","Inclusion Criteria:\n\n* Any adult patient who is planned to undergo bilateral RLE surgery with BCVA 20\u002F30 or better\n* Willing and able to comply with clinic visits and study related procedures\n* Willing and able to sign the informed consent form\n\nExclusion Criteria:\n\n* Patients under the age of 22 or above the age of 75\n* Patients who are pregnant (must be ruled out in a women of child-bearing age with pregnancy test).\n* Patients with active infectious ocular or extraocular disease.\n* Patients actively treated with local or systemic immunosuppression including systemic corticosteriods\n* Paitents with know hypersensitivity to Dexamethasone\n* Patients with severe disease that warrants critical attentino, deemed unsafe for the study by the investigator\n* Patients with a history of ocular inflammation or macular edema\n* Patients with allergy or inability to receive intracameral antibiotic\n* Patients on systemic non-steroidal anti-inflammatory drugs (NSAID) grater than 1,200 mg\u002Fday\n* Patient with a corticosteriod implant (i.e. Ozurdex).\n* Patient with corneal pathology which pre-disposes them to unsatisfactory outcomes",true,"22 Years","75 Years",{"count":87,"type":20},20,[89],"PHASE4","To investigate the outcomes of patients undergoing bilateral RLE surgery with treatment of dexamethasone intracanilicular insert compared to topical standard care steroid. Desiged to look at patient preference comparing the insert to drops and will also look at patient outcomes including inflammatin and risk of cystoid macular edema post-operatively.",[92,26,93,94,95],"Patient Preference","Post-Operative Inflammation","Grade of Post-Operative Cystoid Macular Edema","Rate of Post-Operative Cystoid Macular Edema","2020-09-14",{"date":98,"type":34},"2020-09-16",{"date":96,"type":20},{"date":101,"type":20},"2021-08-27",{"name":103,"class":41},"Vance Thompson Vision - MT"]